- Home
- AIV vs MNKD Comparison
AIV vs MNKD Comparison
Compare AIV & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIV
- MNKD
- Stock Information
- Founded
- AIV 1975
- MNKD 1991
- Country
- AIV United States
- MNKD United States
- Employees
- AIV N/A
- MNKD N/A
- Industry
- AIV Real Estate Investment Trusts
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- AIV Real Estate
- MNKD Health Care
- Exchange
- AIV Nasdaq
- MNKD Nasdaq
- Market Cap
- AIV 1.2B
- MNKD 1.2B
- IPO Year
- AIV 1994
- MNKD 2004
- Fundamental
- Price
- AIV $8.38
- MNKD $3.75
- Analyst Decision
- AIV
- MNKD Buy
- Analyst Count
- AIV 0
- MNKD 6
- Target Price
- AIV N/A
- MNKD $9.33
- AVG Volume (30 Days)
- AIV 911.0K
- MNKD 2.6M
- Earning Date
- AIV 08-11-2025
- MNKD 08-11-2025
- Dividend Yield
- AIV 7.15%
- MNKD N/A
- EPS Growth
- AIV N/A
- MNKD 228.27
- EPS
- AIV N/A
- MNKD 0.10
- Revenue
- AIV $210,828,000.00
- MNKD $297,595,000.00
- Revenue This Year
- AIV $6.96
- MNKD $13.62
- Revenue Next Year
- AIV N/A
- MNKD $15.18
- P/E Ratio
- AIV N/A
- MNKD $36.16
- Revenue Growth
- AIV 9.38
- MNKD 32.50
- 52 Week Low
- AIV $6.89
- MNKD $3.51
- 52 Week High
- AIV $9.49
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- AIV 40.17
- MNKD 43.85
- Support Level
- AIV $8.31
- MNKD $3.81
- Resistance Level
- AIV $8.79
- MNKD $4.13
- Average True Range (ATR)
- AIV 0.16
- MNKD 0.15
- MACD
- AIV -0.05
- MNKD -0.00
- Stochastic Oscillator
- AIV 14.00
- MNKD 11.63
About AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.